CATHERINE MAJCHER: Open Payments
NPI 1861864175 · NILES, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$916 in 35 payments from 21 companies in 2025. Trend: 2023 $457 · 2024 $712 · 2025 $916
Food & beverage: $816Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $157 |
| ABBVIE INC. | 4 | $108 |
| SEAGEN INC. | 1 | $100 |
| Agios Pharmaceuticals, Inc. | 2 | $61 |
| Janssen Biotech, Inc. | 2 | $50 |
| GENZYME CORPORATION | 2 | $39 |
| PharmaEssentia USA Corporation | 1 | $36 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Astellas Pharma US Inc | 1 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
Products named: PYRUKYND, KISQALI, VENCLEXTA, SCEMBLIX, TECVAYLI, BESREMI, ZEJULA, Vyloy.
Industry payments across IL — which companies pay providers there.
